lost weight on semaglutide but not tirzepatide vs Tirzepatide: Loss, Dosing, Timelines & Before and After Results Tirzepatide vs. Semaglutide: Which Weight
Description
J Clin Endocrinol Metab 2025
The phase 2 trial for type 2 diabetes used similar starting doses to the obesity trial, with gradual titration
The median follow-up time to diagnosis after treatment initiation was 3.7 years
A review of recent literature reveals a consistent pattern: patients on semaglutide present with nausea, vomiting, abdominal pain, or early satiety, often in the absence of other identifiable causes
A: Yes, semaglutide injections have been shown to be safe for long-term use in clinical studies
